Search

Your search keyword '"Rabi, Doreen M."' showing total 8 results
Start Over Author "Rabi, Doreen M." Publisher cma impact inc.
8 results on '"Rabi, Doreen M."'

1. Ligne directrice C-CHANGE pour l'harmonisation des lignes directrices nationales de prevention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada : mise a jour 2022

Author

Jain, Rahul, Stone, James A., Agarwal, Gina, Andrade, Jason G., Bacon, Simon L., Bajaj, Harpreet S., Baker, Brian, Cheng, Gemma, Dannenbaum, David, Gelfer, Mark, Habert, Jeffrey, Hickey, John, Keshavjee, Karim, Kitty, Darlene, Lindsay, Patrice, LAbbe, Mary R., Lau, David C.W., Macle, Laurent, McDonald, Michael, Nerenberg, Kara, Pearson, Glen J., Pham, Thuy, Poppe, Alexandre Y., Rabi, Doreen M., Sherifali, Diana, Selby, Peter, Smith, Eric, Stern, Sol, Thanassoulis, George, Terenzi, Kristin, Tu, Karen, Udell, Jacob, Virani, Sean A., Ward, Richard A., Warburton, Darren E.R., Wharton, Sean, Zymantas, Jennifer, Hua-Stewart, Diane, Liu, Peter P., and Tobe, Sheldon W.

Subjects
Anticoagulants (Medicine), Hypoglycemic agents, Cardiovascular diseases -- Care and treatment -- Management -- Prevention -- Cases, Type 2 diabetes, Company legal issue, Company business management, Health
Abstract

L'objectif du projet C-CHANGE (Canadian Cardiovascular Harmonized National Guideline Endeavour), une initiative d'harmonisation des lignes directrices nationales de prevention et de prise en charge des maladies cardiovasculaires, est de faciliter [...]

Published
2023
Full Text
View/download PDF

2. Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update

Author

Jain, Rahul, Stone, James A., Agarwal, Gina, Andrade, Jason G., Bacon, Simon L., Bajaj, Harpreet S., Baker, Brian, Cheng, Gemma, Dannenbaum, David, Gelfer, Mark, Habert, Jeffrey, Hickey, John, Keshavjee, Karim, Kitty, Darlene, Lindsay, Patrice, L'Abbe, Mary R., Lau, David C.W., Macle, Laurent, McDonald, Michael, Nerenberg, Kara, Pearson, Glen J., Pham, Thuy, Poppe, Alexandre Y., Rabi, Doreen M., Sherifali, Diana, Selby, Peter, Smith, Eric, Stern, Sol, Thanassoulis, George, Terenzi, Kristin, Tu, Karen, Udell, Jacob, Virani, Sean A., Ward, Richard A., Warburton, Darren E.R., Wharton, Sean, Zymantas, Jennifer, Hua-Stewart, Diane, Liu, Peter P., and Tobe, Sheldon W.

Subjects
Practice guidelines (Medicine) -- Evaluation, Primary health care -- Methods, Cardiovascular diseases -- Prevention, Health
Abstract

The goal of the Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) process is to give all Canadian health care providers easy access to a comprehensive and practical set of harmonized [...]

Published
2022
Full Text
View/download PDF

4. Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes

Author

Rabi, Doreen M., Padwal, Raj, Tobe, Sheldon W., Gilbert, Richard E., Leiter, Lawrence A., Quinn, Robert R., and Khan, Nadia

Subjects
Merck & Company Inc., Bristol-Myers Squibb Co., Novartis AG, AstraZeneca PLC, Sanofi S.A., Stroke (Disease) -- Complications and side effects -- Care and treatment, Blood pressure, Type 2 diabetes -- Complications and side effects -- Care and treatment, Pharmaceutical industry, Hypertension -- Complications and side effects -- Care and treatment, Health, Care and treatment, Complications and side effects
Abstract

The debate about appropriate blood pressure targets for patients with hypertension and diabetes is of substantial public health importance because the global burden of diabetes and hypertension is large and [...]

Published
2013
Full Text
View/download PDF

5. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Author

Tobe, Sheldon W., Stone, James A., Anderson, Todd, Bacon, Simon, Cheng, Alice Y.Y., Daskalopoulou, Stella S., Ezekowitz, Justin A., Gregoire, Jean C., Gubitz, Gord, Jain, Rahul, Keshavjee, Karim, Lindsay, Patty, L'Abbe, Mary, Lau, David C.W., Leiter, Lawrence A., O'Meara, Eileen, Pearson, Glen J., Rabi, Doreen M., Sherifali, Diana, and Selby, Peter

Subjects
CARDIOVASCULAR diseases, PRIMARY care, HYPERTENSION, PATIENTS, HYPERTENSION risk factors, HEART failure risk factors, STROKE risk factors
Abstract

The article discusses the 2018 update to the Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE), a guideline which targets primary care health care practitioners. The 2018 update includes a total of 77 recommendations and 52 new recommendations, including multifaceted care for patients with cardiovascular risks. The guideline added a new category for hypertension for high-risk individuals and lists of risk factors of heart failure, hypertension and stroke.

Published
2018
Full Text
View/download PDF

6. Intensive lowering of blood pressure: Should we SPRINT?.

Author

Rabi, Doreen M. and Padwal, Raj

Subjects
*SYSTOLIC blood pressure, *THERAPEUTICS, *HYPERTENSION, *CARDIOVASCULAR diseases, *DIABETES risk factors
Abstract

The article discusses the Systolic Blood Pressure Intervention Trial (SPRINT) which challenged the conventional approach to hypertension care. Topics include the consistency of the results with the broader literature, key elements of SPRINT that must be emphasized, and insight provided by the study's results into why the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial showed no benefit.

Published
2018
Full Text
View/download PDF

7. Intensive lowering of blood pressure: Should we SPRINT?

Author

Rabi, Doreen M. and Padwal, Raj

Subjects
SYSTOLIC blood pressure, HYPERTENSION, CARDIOVASCULAR diseases, MEDICAL protocols, ALGORITHMS, BLOOD pressure, ANTIHYPERTENSIVE agents, PHARMACODYNAMICS
Abstract

The author focuses on the challenges posed by the publication of the Systolic Blood Pressure Intervention Trial (SPRINT) on the conventional approaches in caring for hypertension. Topics discussed include the consistent results of SPRINT with the broader literature, the high risk for cardiovascular disease faced by the participants enrolled in SPRINT, and the protocolized care algorithms used by SPRINT for the emphasis of long-acting agents.

Published
2016
Full Text
View/download PDF

8. The authors respond to "Is it premature to SPRINT?".

Author

Rabi, Doreen M. and Padwal, Raj

Subjects
*NIFEDIPINE, *INFARCTION, *BLOOD pressure
Abstract

A response from the authors of an article about blood pressure and the use of secondary prevention reinfarction Israeli nifedipine trial (SPRINT) is presented.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results